IC
JNJ icon

Intersect Capital’s Johnson & Johnson JNJ Stock Holding History

Intersect Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$5.54M Sell
31,201
-1,552
-5% -$277K 1.67% 9
2022
Q1 		$5.8M Buy
32,753
+474
+1% +$80.7K 1.11% 12
2021
Q4 		$5.52M Sell
32,279
-10,741
-25% -$1.76M 1.02% 15
2021
Q3 		$6.95M Sell
43,020
-2,684
-6% -$458K 1.19% 14
2021
Q2 		$7.53M Sell
45,704
-175
-0.4% -$29K 1.33% 13
2021
Q1 		$7.54M Buy
45,879
+1,100
+2% +$178K 1.53% 11
2020
Q4 		$7.05M Buy
44,779
+1,087
+2% +$160K 1.55% 9
2020
Q3 		$6.5M Buy
43,692
+2,206
+5% +$326K 1.75% 8
2020
Q2 		$5.83M Buy
41,486
+5,008
+14% +$730K 1.88% 9
2020
Q1 		$4.78M Sell
36,478
-1,032
-3% -$146K 1.9% 10
2019
Q4 		$5.47M Sell
37,510
-759
-2% -$103K 1.83% 11
2019
Q3 		$4.95M Sell
38,269
-97
-0.3% -$12.8K 1.85% 10
2019
Q2 		$5.34M Buy
38,366
+23
+0.1% +$3.18K 2.07% 9
2019
Q1 		$5.36M Sell
38,343
-342
-0.9% -$45.8K 2.26% 8
2018
Q4 		$4.99M Buy
38,685
+2,852
+8% +$398K 2.39% 8
2018
Q3 		$4.95M Sell
35,833
-139
-0.4% -$18.5K 2.16% 10
2018
Q2 		$4.37M Buy
35,972
+870
+2% +$109K 2.1% 10
2018
Q1 		$4.5M Buy
35,102
+1,590
+5% +$215K 2.38% 9
2017
Q4 		$4.68M Sell
33,512
-328
-1% -$45.7K 2.53% 9
2017
Q3 		$4.4M Sell
33,840
-848
-2% -$112K 2.5% 9
2017
Q2 		$4.59M Buy
34,688
+12,327
+55% +$1.57M 2.75% 7
2017
Q1 		$2.79M Sell
22,361
-5,041
-18% -$602K 2.43% 11
2016
Q4 		$3.16M Buy
27,402
+936
+4% +$108K 2.36% 11
2016
Q3 		$3.13M Sell
26,466
-4,532
-15% -$550K 2.47% 12
2016
Q2 		$3.76M Buy
30,998
+1,246
+4% +$142K 2.26% 11
2016
Q1 		$3.22M Buy
29,752
+9,267
+45% +$959K 2.02% 13
2015
Q4 		$2.1M Buy
20,485
+356
+2% +$35.8K 1.81% 16
2015
Q3 		$1.88M Buy
20,129
+3,104
+18% +$300K 1.73% 16
2015
Q2 		$1.66M Buy
17,025
+1,281
+8% +$128K 1.41% 19
2015
Q1 		$1.56M Buy
15,744
+1,917
+14% +$195K 1.2% 19
2014
Q4 		$1.45M Buy
+13,827
New +$1.46M 1.21% 21

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Intersect Capital's JNJ Position: Q2 2022 in Review

Intersect Capital reduced its Johnson & Johnson (JNJ) stake by 4.7% in Q2 2022, selling an estimated $277K and leaving 31,201 shares worth $5.54M. The position accounts for 1.67% of the portfolio, ranked #9.

Intersect Capital first reported a position in JNJ in Q4 2014 and has held it in 31 quarters since. The position peaked at $7.54M in Q1 2021. 3,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

  • Intersect Capital held 31,201 shares of Johnson & Johnson worth $5.54M as of Q2 2022.
  • Intersect Capital sold 1,552 Johnson & Johnson shares in Q2 2022, an estimated $277K.
  • Johnson & Johnson made up 1.67% of Intersect Capital's portfolio in Q2 2022, its #9 holding.
  • Intersect Capital first reported a position in Johnson & Johnson in Q4 2014 and has held it in 31 quarters since.
  • Intersect Capital's Johnson & Johnson position peaked at $7.54M in Q1 2021.
  • 3,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.